Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting

December 4, 2010 By Bio-Medicine.Org

SOUTH SAN FRANCISCO, Calif., Dec. 4, 2010 /PRNewswire/ —
Portola Pharmaceuticals, Inc. today announced the presentation of
preclinical study results for its novel Syk and JAK inhibitor
program at the American Society of Hematology’s 52nd Annual Meeting
and Exposition. Portola’s novel Syk and JAK inhibitors are in
development to treat chronic inflammatory diseases, including
rheumatoid arthritis, and certain cancers, including non-Hodgkin’s
lymphoma and chronic lymphocytic leukemia.

Poster Presentation Details

Specific Inhibition of Syk Suppresses Leukocyte Immune Function
and Alleviates Inflammation In Rodent Models of Rheumatoid
Arthritis

  • Presenter: Greg Coffey, Ph.D., Portola
    Pharmaceuticals
  • Poster Session: Lymphocytes, Lymphocyte Activation and
    Immunodeficiency, Including HIV and Other Infections: Poster I
  • Date: Saturday, December 4, 5:30 – 7:30 p.m. ET
  • Location: Hall A3/A4 (Orange County Convention Center)
  • Poster Board I-707

P505-15, a Highly Selective SYK Inhibitor, Shows Significant
Activity in Primary CLL Cells and is Synergistic with Fludarabine
at Low Concentrations

  • Presenter: Stephen Spurgeon, M.D., Oregon Health &
    Science University Knight Cancer Institute
  • Poster Session: Lymphoma – Pre-Clinical – Chemotherapy
    and Biologic Agents: Poster I
  • Date: Sunday, December 5, 6:00 – 8:00 p.m. ET
  • Location: Hall A3/A4 (Orange County Convention
    Center)
  • Poster Board II-719

Spleen Tyrosine Kinase (Syk) Inhibitors Block B Cell Receptor
Signaling and Survival In Chronic Lymphocytic Leukemia

  • Presenter: Jan Burger, M.D., Ph.D., MD Anderson Cancer
    Center
  • Poster Session: CLL – Biology and Pathophysiology,
    excluding Therapy:

    ‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech